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SPECIAL ISSUE ON BIOSOCIAL APPROACHES TO THE
CONTROL OF NEGLECTED TROPICAL DISEASES
NEGLECTED TROPICAL DISEASES IN
BIOSOCIAL PERSPECTIVE
MELISSA PARKER*1, KATJA POLMAN† AND TIM ALLEN‡
*Department of Global Health and Development, London School of Hygiene and
Tropical Medicine, UK, †Institute of Tropical Medicine, Antwerp, Belgium and
‡Department of International Development, London School of Economics, UK
Summary. The term ‘neglected tropical diseases’ (NTDs) points to the need for a
biosocial perspective. Although ‘diseases’ are widely understood as biological phe-
nomena, ‘neglect’ is inherently social. Social priorities, social relations and social
behaviour profoundly inﬂuence the design, implementation and evaluation of
control programmes. Yet, these dimensions of neglect are, themselves, neglected.
Instead, emphasis is being placed on preventive chemotherapy – a technical,
context-free approach which relies almost entirely on the mass distribution of
drugs, at regular intervals, to populations living in endemic areas. This article
reﬂects on the processes which have enabled an NTD ‘brand’ identity to emerge,
and it comments on a disquieting disengagement with some of the more critical
insights about the consequences of mass drug administration. Building on the
work of biosocial scholars studying other aspects of health and disease, a more
adequate, evidence-based approach is delineated. Developing such an approach
is an iterative process, requiring on-going engagement with both biological and
social insights as they emerge. Considerable theoretical, methodological and
political challenges lie ahead, but it is essential they are overcome, if the sustain-
able control of NTDs is to become a reality.
Introduction
The term ‘neglected tropical diseases’ (NTDs) points to the need for a biosocial
perspective. Although ‘diseases’ are typically understood as biological phenomena,
‘neglect’ arises from social priorities, social relations and social behaviour. Yet, more
often than not, the dual aspect of NTDs is set aside in the design, implementation and
1 Corresponding author. Email: melissa.parker@lshtm.ac.uk
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evaluation of control programmes. Instead, emphasis is placed on preventive
chemotherapy, an approach which relies heavily on the mass distribution of drugs, at
regular intervals and free of charge, to populations living in endemic areas. Framed as
technical solutions, NTD control programmes are rolled out across countries and
continents, irrespective of the speciﬁc contexts in which they are delivered. Writing from
diverse viewpoints, and citing numerous examples, the authors contributing to this
special issue make the case for a re-orientation in both research and policy.
Challenges facing the NTD ‘brand’
Ideas underpinning contemporary approaches to the control of NTDs relate to the work of
the Great Neglected Diseases (GND) network of the 1970s and 1980s (Hotez et al., 2008;
Regnier, 2012; Keating, 2014). During the years before and after the turn of the new
Millennium, there was a concerted effort to link the philanthropic aspects of the GND
network, which focused on particular tropical infections (such as schistosomiasis), with an
approach that replicated key aspects of UNICEF’s selective primary health care strategies of
the 1980s (Allotey et al., 2010; Regnier, 2012). Emphasis was placed on the reported health
and economic beneﬁts that had accrued in the past from the treatment for parasitic worms in
afﬂuent countries (Bleakley, 2002; Miguel & Kremer, 2004), and an argument was made that
there were effective medicines that might be used on a large scale. As one of the main
advocates, Lorenzo Savioli, put it: there was a ‘paradigm shift’ entailing: ‘a strategic
rethinking and move away from a “theoretical”, structural classiﬁcation based on disease
biology towards a “practical” one based on the available tools…’ (Savioli et al., 2011, p. 481).
Together with other like-minded ﬁgures, Savioli promoted ‘NTDs’ as a ‘brand identity’,
and campaigned to establish mass drug administration as an appropriate response (Savioli
et al., 2011; Molyneux, 2012). Building on discussions at a meeting convened by the World
Health Organization in 2003, a ‘Department of Control of Neglected Tropical Diseases’ was
set up in Geneva under his leadership. Then, in 2005, a Global Network for NTDs was
launched to raise the proﬁle of this group of diseases, and encourage a shift away from the
emphasis on HIV/AIDS, malaria and tuberculosis (Allen & Parker, 2011; Nordrum, 2015).
The overall intention was to raise awareness, and secure funds, political will and supplies of
medications, with a view to systematically controlling the NTDs. The strategy was explicitly
linked to the Millennium Development Goals, which had mentioned the need to combat
‘other diseases’ alongside HIV/AIDS and malaria.
Targets were promoted for the mass treatment of populations living in endemic
areas, and far-reaching claims were made about the possible beneﬁts. For example,
inﬂuential articles by three leading advocates, Molyneux, Hotez and Fenwick, argued
that controlling the NTDs has the potential to ‘make poverty history’ (Molyneux et al.,
2005, p. 106) and to ‘rescue the bottom billion from poverty’ (Hotez et al., 2009,
p. 1570). By the end of the decade, the WHO had released its ﬁrst global report on NTDs
(WHO, 2010), and the Director General could proclaim that: ‘WHO leadership [has]
brought the neglected tropical diseases from obscurity into the limelight. These
Cinderella diseases, long ignored and underappreciated, are a rags-to-riches story’
(Chan, 2012). An indication of the enthusiasm for the approach at that time is reﬂected
in Savioli’s published remarks at an Institute of Medicine workshop. He acknowledged
that there were regional speciﬁcities, but suggested that this complicated global efforts to
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reduce the burden of NTDs. He then went on to quote a famous Formula One
racing driver: ‘If you think you have everything under control, you are not going fast
enough… that’s the way we need to deal with the issue sometimes’ (Choffnes & Relman,
2011, p. 56).
Seventeen ‘core’ NTDs have been foregrounded by the WHO (WHO, 2010, 2013);
and it has been argued that seven of them can be controlled or eliminated by utilizing
preventive chemotherapy. This approach has been deﬁned as ‘the large-scale delivery
of safe, single-administration, quality-assured medicines, either alone or in combination,
at regular intervals, to entire population groups’ (WHO 2015a, p. 50). It aims to
reduce infection and prevent the development of severe morbidity. The diseases being
targeted in this way are: lymphatic ﬁlariasis, onchocerciasis, schistosomiasis,
soil-transmitted helminthiases (notably ascariasis, trichuriasis and hookworm) and
trachoma. The WHO’s willingness to promote preventive chemotherapy would not have
occurred without the widespread availability of four drugs (albendazole, ivermectin,
praziquantel and azithromycin) to treat these diseases. Pharmaceutical companies, such
as Merck and GlaxoSmithKline, have donated hundreds of millions of these drugs. This
has helped trigger political momentum, and thus enabled the allocation of substantial
resources and ﬁnance. By December 2012, an estimated US$3.2 billion had been
donated from diverse sources (Policy Cures, 2012), including bilateral agencies such as
USAID and the UK Department for International Development, UN agencies, the
World Bank, philanthropic institutions such as the Bill and Melinda Gates Foundation
and international NGOs such as the End Fund. Even those who have been at the centre
of promoting mass drug administration recognize that calling the diseases ‘neglected’ has
now become a misnomer. As Fenwick, a key ﬁgure in the promotion of mass drug
administration, recently said: ‘If 700 million people are receiving treatment free of
charge, how neglected are they? However, having sold the brand, we don’t want to
destroy it quite yet’ (quoted in Nordrum, 2015).
There is no doubt that establishing the NTD ‘brand’ has been a remarkable
achievement. There is widespread agreement that it is reasonable and appropriate to
focus on debilitating infections that afﬂict impoverished people. It is also irrefutable that
huge numbers of tablets have become available to populations that, in the not so distant
past, were largely ignored. However, there are increasing concerns with relying so
heavily on the mass distribution of drugs, and these have been expressed by biological
and social scientists alike.
First, while the prevalence and intensity of infection usually declines following mass
treatment for NTDs, they often return to their former levels in the absence of wider
socioeconomic changes (e.g. Saeed et al., 2006; Nikolay et al., 2015; Amin & Abu Baker,
2016). Given this, an argument could be made for making an indeﬁnite commitment to
mass drug administration. However, this raises a second concern: the possibility of
declining effectiveness and/or resistance occurring to front-line drugs. The point has been
elaborated, for example, with respect to praziquantel (Gryseels et al., 2006; Mahmoud &
Zerhouni, 2009; Gray et al., 2010), albendazole (Geerts & Gryseels, 2000; Waghorn,
2006; Humphries et al., 2012) and the combined use of ivermectin with albendazole
(Simonson et al., 2010).
A third issue concerns the fact that drug coverage levels are variable, and they often
fall below the levels required to systematically control infection. Explanations for low
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drug coverage vary not only between the diseases being treated, but also within and
between countries for any one disease, reﬂecting the fact that historical, political,
economic and social issues powerfully inﬂuence local responses to mass drug
administration (e.g. Parker et al., 2008, 2012; Hastings, 2013, 2016). The drugs
themselves can also have a direct impact on coverage levels, simply because some of
them are easier to swallow than others. In many instances it has been shown that
irrespective of the reported coverage levels, large numbers of people being targeted either
refuse to swallow them or they are not offered them in the ﬁrst place (e.g. Ranganath,
2010; Parker & Allen, 2011, 2013; Roy et al., 2013; Muhumuza et al., 2013, 2015;
Kisoka et al., 2014, 2016; Tuhebwe et al., 2015).
These points relate to a fourth broad area of concern: the role of drug distributors in
mass treatment programmes. In countries where great reliance is placed on unpaid (and
usually poorly trained) volunteers to distribute drugs, it has been shown that they are
rarely able to provide convincing explanations for the need to take these drugs, particularly
when someone has no signs or symptoms of infection or the likelihood of re-infection is
perceived to be high (e.g. Parker & Allen, 2011; Samsky, 2012; Kisoka et al., 2016).
A ﬁfth challenge evident in the literature is the fact that current approaches to
implementing mass drug administration programmes can have adverse effects on already
fragile and over-stretched health systems (Coulibaly et al., 2008; Cavalli et al., 2010;
Marchal et al., 2011; Meheus et al., 2012). Along these lines, it has also been argued that
when donors require parallel drug distribution mechanisms to be established, the
‘competing’ programmes can create confusion at a local level. Indeed, they can end up
deﬂecting attention away from other priorities and make sustainable, broad-based
primary care more difﬁcult to achieve (Yamey, 2009; Kabatereine et al., 2010). For some
analysts, there has been too much focus on the vertical delivery of tablets, and the lack of
attention to the social and political context has marked a counter-productive resurgence
of simplistic ‘magic bullet’ medicine (Allotey et al., 2010).
A biosocial way forward?
A diverse group of biological and social scientists have contributed to the literature cited
above. Taken together, their work comprises a serious critique of current endeavours to
rely on mass drug administration to control NTDs. In July 2013, some of these scholars
attended an international workshop at the Royal Anthropological Institute and Brunel
University, London. It was organized under the auspices of the Biosocial Society.
The idea was to make a concerted effort to move beyond the exaggerated rhetoric
surrounding strategies to control NTDs, as well as the unhelpful polarities between
the biological and social sciences; and to explore the possibility of developing integrated,
biosocial approaches to the control of NTDs. Most of the articles published in this
special issue were originally presented at the workshop. The discussion was lively, and
occasionally fraught. Starting points were very different. Nevertheless, a consensus
emerged that developing biosocial approaches to the control of NTDs was a useful
way forward.
Such approaches build directly on the work of Goodman and Leatherman (1998),
Kleinman et al. (2008), Leatherman and Goodman (2011), Farmer et al. (2013) and
Singer (2015), all of whom have argued the case for developing critically engaged,
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biosocial perspectives on health and disease. Their work does not focus on NTDs, but
it is useful nonetheless. Goodman and Leatherman’s edited collection Building a New
Biocultural Synthesis, for example, usefully identiﬁes some of the epistemological
challenges; and emphasizes the need for researchers to reﬂect on the way in which
historical, political, social and economic relations shape power relations and the impact
this can have on ‘local biologies’ (Goodman & Leatherman, 1998, p. 15). ‘Local
biologies’ is a term associated with the work of Margaret Lock (Lock, 1993, 2001),
who has challenged the notion of homogeneous and universal biological knowledge, and
has argued that understandings of the body, and therefore of diseases, ceaselessly
interact with local environments, and are indistinct from other aspects of culture.
Dressler (2003) and Dufour (2006), having acknowledged the enormous contribution
of this earlier work, go on to ask: what’s cultural about biocultural research? Dufour
suggests that much too much emphasis has been given to the ‘biological’ rather than the
‘cultural’ dimensions, while Dressler suggests that a rather descriptive and simplistic
approach has been taken to the study of culture; and that it is important to develop
a more serious theoretical engagement with the concept of culture for truly biocultural
research to occur. He illustrates the latter point with reference to research exploring
the inter-relationships between psychological stress, economic inequality and cultural
processes.
Singer and Clare (2003), Kleinman et al. (1997, 2008), Sommerfeld (2003), Farmer
et al. (2013) and Alley and Sommerfeld (2014) all emphasize the multi-disciplinary
nature of biosocial research. They rightly point out that it is a collaborative venture
which necessarily involves drawing upon insights from a diverse range of disciplines in
the biological and social sciences. For some of these scholars, social suffering and
structural violence are central concepts in biosocial approaches to disease and suffering,
with the term ‘social suffering’ being used to highlight ‘what political, economic and
institutional power does to people and, reciprocally, how these forms of power
themselves inﬂuence responses to social problems’ (Kleinman et al., 1997, p. ix). Thus, a
biosocial approach necessarily focuses on the inter-connections between biological and
social aspects of life – and the multiple ways in which political, social, economic and
historical issues at local, national and international levels inﬂuence and frame these
relationships. Crucially, and this is the really difﬁcult bit, it involves trying to do so on
equal terms, or maybe, as Ingold and Palsson (2013) propose, to reject the distinction
altogether, and attempt a uniﬁed approach to understanding the biological and social
dimensions of human life.
Against this backdrop, it is helpful to ask: what constitutes a biosocial approach to
the control of NTDs? Can it be achieved? Ideally, a biosocial approach involves drawing
upon insights emerging from zoology, parasitology, ecology, epidemiology, clinical
medicine and pharmacology; whilst simultaneously taking seriously, and giving equal
weight to, insights emerging from anthropology, history, demography, economics and
political science. It necessarily involves undertaking research with multiple methods, and
investing time in thinking through how to put together insights from different disciplines
in order to develop a more holistic understanding of: the impact of NTDs on overall
health and well-being; the effects of current control and elimination strategies on the
overall health of populations; the way in which global health governance and
international ﬁnance shape national NTD programmes; the impact of these changes
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on local biologies; as well as an exploration of how global policies are understood at
village, district and national levels. Developing such an approach is an iterative process,
requiring on-going engagement with both biological and social insights as they emerge.
Disciplinary tramlines and the status of evidence
Considerable challenges lie ahead. In the world of NTDs, and global health more
generally, it would be fair to say that it is rare indeed for an epidemiologist, parasitologist
or public health specialist to work on an equal footing with an anthropologist, historian
or political scientist. It is much more common for scholars to work either in parallel
tramlines or for social scientists to be employed (often in fairly junior positions) in schools
of public health as ‘handmaidens of biomedicine’, undertaking ‘qualitative’ social research
(Allen & Parker, 2012a). ‘Qualitative’ research typically elaborates a ‘factorial model of
disease’ with complex social and cultural processes being conceptualized as discrete,
measurable ‘factors’, acting as ‘barriers’ to the effective implementation of global health
interventions (Parker & Harper, 2006). Such work quickly becomes divorced from
theoretical engagements in the social sciences and ends up lacking critical rigour, thereby
leaving normative and simplistic ways of seeing unchallenged and reinforcing unhelpful
assumptions about targeted populations.
There are multiple reasons for the enduring nature of this state of affairs, including
the fact that critically engaged research undertaken by anthropologists and other social
scientists often reveals the mistaken assumptions embedded in global health
interventions as well as the unique ways in which interventions are shaped by the
particular political, historical, social and economic contexts in which they are delivered.
It can be difﬁcult to revise interventions in the light of this kind of research, not least
because adjustments typically require spending more money, rather than less, and in the
eyes of donors, this makes the interventions less cost-effective and appealing.
Equally challenging is the fact that it is not always clear how to value different kinds
of evidence. If a randomized control trial monitoring the effects of annual treatment on
microﬁlarial loads at a sentinel surveillance site suggests that mass drug administration is
effective at reducing the transmission of lymphatic ﬁlariasis, and ethnographic and
survey research in neighbouring districts suggests that drug coverage is low, is it
appropriate to reify one set of ﬁndings over another? Similarly, if a cohort study
documenting changing patterns of infection among children suggests that annual
treatment for schistosomiasis prevents severe morbidity, but social research undertaken
in the same area suggests that migration prevents the majority of children from attending
school on a regular basis, how should these different kinds of data be combined to assess
the merits of a programme? If ethnographic research shows how social, economic and
political issues inﬂuence the uptake of drugs at a local level – so much so, that in some
places the same programme may have entirely different impacts within and between
districts and regions – what are Ministries of Health, the World Health Organization
and donors such as the Bill and Melinda Gates Foundation meant to do with such
information? Should there be an anthropologist in every village monitoring the situation
or is there another solution? What form should it take?
Engaging with biosocial issues raises a variety of other questions relevant to global
health interventions more broadly. If, for example, conceptions of ‘the social’ among
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biomedical scientists are perceived by more critically inclined social scientists as being too
simple, how should we proceed with more complex, nuanced understandings of
what constitutes social life? It is fairly straightforward to show that external notions
of a community living in social harmony often bear little relationship to local realities; and
that projecting social harmony onto village life is unhelpful if global health programmes are
to run effectively at a local level. However, it is far from clear what to do with ethnographic
data revealing the complexity of social life in village settings. This is a particularly
important point with respect to mass drug administration. For example, as indicated
previously, many NTD programmes rely on unpaid, poorly trained volunteers to distribute
drugs for the beneﬁt of their ‘community’. Such programmes assume that they will be
willing to spend considerable amounts of time distributing drugs to everyone in their
village, disregarding social and political divisions and overcoming economic constraints.
The reality is rather different: gender, kin, religious, political, occupational and economic
issues all inﬂuence the distribution of drugs within villages; and it is not unusual for the
most marginal and vulnerable populations to be the least likely to be offered treatment
(Boelaert et al., 2009; Parker et al., 2012; Parker & Allen, 2013). Addressing these issues
can feel insurmountable in a context when there is so much emphasis on scaling-up and
increasing the number of people to be targeted, rather than reﬂecting on existing strategies
to see whether a more diverse, multi-pronged (and probably more expensive) approach
might work more effectively in practice.
This raises a further problem: the nature of evidence and the politics of (expert)
knowledge. It is sometimes assumed that research, whether grounded in the social or
biological sciences, will gradually enable the appropriate reﬁnement of policies in the
light of key ﬁndings. Such assumptions are mistaken. The relationship between evidence,
policy and practice is neither simple nor causal (see Mosse, 2004, 2005 and 2013 for a
useful discussion of these complexities in other ﬁelds of international development).
There is often a clear hierarchy of evidence, with randomized control trials typically
being presented as the epitome of high-quality research, and background information
and expert opinion being presented as the lowest form of information. Insights emerging
from historical or ethnographic research sometimes do not even feature in this pyramidal
evidence hierarchy (Adams, 2013).
With respect to NTDs, the situation is additionally complicated by the fact that the
broader political context in which mass drug administration has emerged as the primary
strategy for controlling these diseases has not only inﬂuenced the design of mass drug
administration programmes, but also the type of monitoring and evaluation undertaken
once the programmes have been rolled out. For example, ‘knowledge, attitudes and
practice’ surveys (which are relatively cheap and superﬁcial) are often funded at the
expense of long-term ethnographic research. In other words, the political economy of
research has profoundly inﬂuenced the kind of evidence that is produced (and not
produced); the kind of debate that has subsequently occurred (and not occurred);
and the way in which particular kinds of evidence have been used in preference
to other kinds of evidence. The end result has been a lack of triangulated research
assessing the consequences of mass drug administration. There is an acute need for
independent, rigorous assessments examining locally speciﬁc effects, and subjecting
reported results to appropriate critical scrutiny (Allen & Parker, 2012b; Parker &
Allen, 2014).
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Interestingly, Chris Whitty, acting in his capacity as the Director of Research and
Chief Scientiﬁc Adviser at the UK’s Department for International Development,
implicitly acknowledged this point in a talk to members of parliament in London in
December 2012. He highlighted the dangers of foregrounding certain kinds of evidence
at the expense of other kinds of evidence, and the hazards of exaggerating the results of
treatment programmes. In particular, he referred to data on the control of leprosy which
suggested considerably greater reductions in prevalence than was actually the case. The
result was that donors reduced their funding for leprosy control in the mistaken belief
that the disease is no longer a serious problem. He went on to note that the targets being
emphasized to secure support for control programmes for other NTDs (such as
lymphatic ﬁlariasis) could end up being similarly counter-productive.
Revealing the value of biosocial research
Although the theoretical, methodological and political challenges of developing
biosocial approaches to controlling or eliminating NTDs are considerable, it is vital
to ﬁnd ways to overcome them. All the articles published in this special issue illustrate
the point. They either reﬂect critically on research that does not combine insights from
the biological and social sciences – and demonstrate how over-reliance on biological
or social approaches limits our understanding of transmission, control or prevention – or
they highlight how a biosocial perspective can further our understanding of
transmission, control or prevention of NTDs.
The article by Hastings (2016) illustrates how easy it is for NTD control programmes
to be de-railed when limited attention is paid to the social, economic and political
contexts in which mass treatment is delivered. In the course of long-term ethnographic
ﬁeldwork in Morogoro, Tanzania, riots broke out while teachers were handing out
medicines to school children for the prevention and treatment of S. haematobium. These
riots occurred in other parts of Tanzania too and the mass drug administration
programme was halted. By analysing the rumours and violence surrounding the
programme, Hastings’ article demonstrates what happens when policymakers and
practitioners focus on the technical aspects of delivery at the expense of engaging with
the speciﬁc local contexts.
Stothard et al. (2016) also discuss local understandings and responses to infection
with S. haematobium among school children in Tanzania. Focusing on Unguja Island
(Zanzibar), their research highlights the limitations of relying solely on health education
in schools to alter knowledge and understanding of the life-cycle of schistosomiasis.
They go on to suggest that it would be a mistake to assume that children will ‘rationally’
reduce their contact with contaminated water. Reminding us that only a small number
of infected children are needed to sustain the transmission of schistosomiasis, and such
transmission can easily occur among pre-school children, their article provides as strong
a case as any for social and biological scientists to avoid placing too much emphasis on
school-based interventions and to develop broader, more integrated, biosocial
approaches to the control of schistosomiasis.
The article by Person et al. (2016) is similarly concerned with controlling schistosomiasis
on Unguja Island. Recognizing that community engagement has predominantly been
limited to carrying out protocols designed either nationally or internationally, with little – if
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any – consideration for local circumstances, their article presents a new approach whereby
local actors are actively involved in the design of interventions seeking to control
schistosomiasis. Structural interventions (such as the design of locally appropriate sanitation
facilities and laundry washing facilities) are created alongside the development of education
materials about schistosomiasis for school children, with a view to modifying risk behaviours
and increasing drug coverage. The work is in progress, with the multi-disciplinary approach
promising to make a really useful contribution to reducing transmission.
Pearson’s biosocial research (Pearson, 2016), which combines the collection of
parasitological data with long-term ethnographic ﬁeldwork, examines the low level of
schistosomal infection among ﬁsherfolk living along the River Nile in northern Uganda.
Her research suggests that while mass drug administration has contributed to a
reduction in the prevalence and intensity of S. mansoni, this would not have occurred in
the absence of wider environmental, social and political changes. Such changes included
changing ﬁshing livelihoods, local attitudes to public health interventions, access to
water and sanitation facilities, hygiene practices and the use of anti-malarial treatments.
Bardosh et al. (2016) focus on a zoonotic tapeworm, Echinococcus granulosus, in
northern Morocco. Infection with this tapeworm can not only lead to losses in livestock
production, but also to the development of a serious disease, cystic echinococcosis, in
humans. Building on clinical and epidemiological research, Bardosh et al. show how
ethnographic ﬁeldwork at Moroccan slaughterhouses can usefully reveal the biosocial
pathways facilitating the spread of the tapeworm between dogs, livestock and people.
Grounded in an understanding of the political economy of the region, their article rightly
calls for a participatory and critically engaged biosocial approach to the control of this
neglected zoonotic disease.
Finally, Allen and Parker (2016) draw upon ﬁeld research in East Africa to provide
an assessment of school-based mass drug administration. They show how a key study by
Miguel and Kramer (2004) of deworming in Kenya has been much cited as evidence for
the effectiveness of large-scale MDA programmes targeting entire populations.
However, the ﬁndings from this study have been seriously questioned, and this has led
to a ﬁerce debate termed the ‘Worm Wars’ (Evans, 2015). Allen and Parker go on to
critically review literature relating to these issues, demonstrating that many claims made
about the success of deworming school children in Africa are misleading. Moreover,
evidence relating to school-based programmes at various research sites in Uganda and
Tanzania shows that actual tablet consumption by children is much lower than has been
suggested. The effects differ between the diseases being targeted, but it is clear that the
effective delivery of treatments to children requires rethinking in order to sustain any
improvement in their well-being.
Conclusion: reversing rhetorics and wrong turnings
The word ‘neglected’ in neglected tropical diseases emphasizes social priorities, social
relations and social behaviour. It is, therefore, odd that public health interventions for
the control of NTDs are persistently framed as technical solutions, which can be rolled
out in a uniform way across countries and continents. Regrettably, as time has passed,
much of the focus has continued to be on raising funds and scaling-up mass drug
administration. Concerns about the biological and social implications of this approach
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have tended to be side-lined, and independent evidence of all kinds has played a
worryingly marginal role.
Back in 2011, as part of a collection of articles on the Millennium Development Goals,
a critical assessment was made of contemporary approaches to the control NTDs. It was
pointed out that optimistic assertions by leading protagonists were open to question.
Findings from ﬁeldwork among those at the receiving end of mass drug administration
indicated that rhetoric was being emphasized over realities. Without a series effort to
assess what is actually happening on the ground, the achievements of the NTD lobby in
highlighting the signiﬁcance of debilitating afﬂictions could end up being undermined.
Indeed, the important work of addressing the health needs of impoverished people might,
in practice, be reversed (Allen & Parker, 2011).
At the time, this was a highly contentious argument, and it prompted some heated
exchanges (Reisz, 2013). Five years later, a plethora of studies have subsequently
underlined the points made, and indiscriminate mass drug administration programmes
are now being subjected to much greater scrutiny (Garner et al., 2015). Nevertheless,
large-scale mass drug administration is continuing, and in some ways, positions have
hardened. For example, a Cochrane Review on soil-transmitted helminth infections
recently concluded that for routine deworming of school children in endemic areas:
‘there is quite substantial evidence that programmes do not show beneﬁt in terms of
average nutritional status, haemoglobin, cognition, school performance, or death’
(Taylor-Robinson et al., 2015). In response, the WHO’s Advisory Group on NTDs has
continued to claim that mass deworming is: ‘the most cost-effective strategy to reach
infected children and improve their health and well-being’ (WHO, 2015b).
Given how much is at stake, it is unsurprising that some responses to critical
perspectives remain defensive. Nevertheless, there is an urgent need for more balanced,
less confrontational and better informed discussions. To that end, the articles in this
collection try to shift the terms of debate. Rather than rejecting the possibility of
controlling NTDs, the authors suggest that developing biosocial approaches potentially
offers a more effective way of achieving positive and sustainable outcomes. They also
demonstrate how biosocial perspectives add rigour to scholarly analyses. Controlling
debilitating and curable ailments that afﬂict the world’s poorest people is a laudable
aim, but without the kinds of insights presented here, what have been promoted as
short-cuts linked to the availability of free drugs will almost inevitably turn out to be
wrong turnings.
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